Project Grant HT9425261E358
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Sarasota, FL 34243, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $817,027 Project Grant to The Roskamp Institute, Inc. in Sarasota, Florida under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, running from August 15, 2023 to August 14, 2026, will support the institute's research on an "amnion-derived multipotent cell secretome-medicated therapy for Gulf War Illness." The Roskamp Institute is a non-profit biotechnology research organization that has previously...
- Federal Project Grant Award Summary The Roskamp Institute, Inc. received a $3.27 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on September 15, 2025, with performance extending through September 14, 2029. The award funds research to delineate the therapeutic effects of a novel blood-brain barrier (BBB)-penetrable peroxisome proliferator-activated receptor (PPAR) agonist on chronic outcomes following...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $769,999 to the South Florida Veterans Affairs Foundation For Research And Education, Inc. under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026 through July 31, 2029. The project investigates sphingolipids and eicosanoids derived from plasma and tear fluid as disease-relevant biomarkers in Gulf War Illness. This three-year research initiative will be conducted at the awardee's...
- This federal Project Grant award for $327,194 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Roskamp Institute, Inc., a biotechnology research organization based in Sarasota, Florida. The purpose of this 3-year award, with a performance period from September 1, 2024 to August 31, 2027, is to conduct research on delineating the therapeutic effect of PTEN inhibition for mitigating chronic microglia activation and the...
- The Defense Health Agency awarded a $1,633,104 Project Grant to The Roskamp Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420) to develop highly selective DYRK1A inhibitors as a novel therapeutic approach for traumatic brain injury. The grant, which runs from June 15, 2024 to June 14, 2028, supports the organization's research to understand the causes of and find cures for neuropsychiatric and neurodegenerative disorders. The Roskamp Institute, a non-profit...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Princeton University $590.4K under the Military Medical Research and Development program (CFDA 12.420) to develop a pathophysiologically-based diagnostic biomarker signature for Gulf War Illness based on an epigenetic innate immune memory hypothesis. The three-year project, which commenced July 1, 2025 and concludes June 30, 2028, will be conducted at Princeton's Office of Research and Project Administration in...
- The Defense Health Agency awarded a $489,997 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Roskamp Institute, Inc. in Sarasota, Florida. The grant, awarded on September 1, 2024, will fund research to delineate the therapeutic effect of PTEN inhibition on mitigating chronic microglia activation and the chronic sequelae of repetitive mild traumatic brain injury (mTBI). The Roskamp Institute, a non-profit biotechnology research organization, has...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Veterans Medical Research Foundation of San Diego a $2,074,865 Project Grant effective September 1, 2025, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award funds research to develop machine learning algorithms that utilize pre-intervention supraspinal functional connectivity imaging data to predict patient responsiveness to repetitive transcranial magnetic stimulation...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $713,277 to Boston University Medical Campus to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The award will support the project from September 1, 2024 through August 31, 2027. As part of this...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $2,065,452 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research titled "An Epigenetic Innate Immune Memory Hypothesis for Gulf War Illness: Development of a Pathophysiologically Based Diagnostic Biomarker Signature," which includes a fourth specific aim under...